Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-Based Protein Profiling

被引:2
|
作者
Sprager, Ernest [1 ,2 ]
Moeller, Jens [3 ]
Lin, Yuhsien [3 ]
Reisinger, Veronika [3 ]
Bratkovic, Tomaz [1 ]
Lunder, Mojca [1 ]
Vasl, Jozica [2 ]
Krajnc, Aleksander [2 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[2] Novartis Pharmaceut Mfg LLC, Novartis Tech Res & Dev, Biol Tech Dev Menge, Ljubljana, Slovenia
[3] Novartis Pharmaceut Mfg GmbH, Novartis Tech Res & Dev, Analyt Characterizat, Kundl, Austria
关键词
Antibody drug(s); Enzyme(s); Protein formulation(s); Hydrolysis; Liquid Chromatography-Mass spectrometry (LC-MS); Monoclonal antibody(s); Surfactant(s); B-LIKE; 2; SERINE HYDROLASES; DEGRADATION; PROTEOMICS; PRODUCTS; IMPACT; HCPS; INHIBITION; HYDROLYSIS; STABILITY;
D O I
10.1016/j.xphs.2024.05.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polysorbate (PS) degradation in monoclonal antibody (mAb) formulations poses a significant challenge in the biopharmaceutical industry. PS maintains protein stability during drug product's shelf life but is vulnerable to breakdown by low-abundance residual host cell proteins (HCPs), particularly hydrolytic enzymes such as lipases and esterases. In this study, we used activity-based protein profiling (ABPP) coupled with mass spectrometry to identify acyl-protein thioesterase-1 (APT-1) as a polysorbate-degrading HCP in one case of mAb formulation with stability problems. We validated the role of APT1 by matching the polysorbate degradation fingerprint in the mAb formulation with that of a recombinant APT1 protein. Furthermore, we found an agreement between APT1 levels and PS degradation rates in the mAb formulation, and we successfully halted PS degradation using APT1-specific inhibitors ML348 and ML211. APT1 was found to co-purify with a specific mAb via hitchhiking mechanism. Our work provides a streamlined approach to identifying critical HCPs in PS degradation, supporting quality-by-design principles in pharmaceutical development. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:2128 / 2139
页数:12
相关论文
共 50 条
  • [41] Identification and characterization of host cell protein product-associated impurities in monoclonal antibody downstream processing
    Levy, Nicholas E.
    Valente, Kristin
    Lee, Kelvin H.
    Lenhoff, Abraham M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [42] Profiling of MicroRNA Targets Using Activity-Based Protein Profiling: Linking Enzyme Activity to MicroRNA-185 Function
    Filip, Roxana
    Desrochers, Genevieve F.
    Lefebvre, David M.
    Reed, Alex
    Singaravelu, Ragunath
    Cravatt, Benjamin F.
    Pezacki, John Paul
    CELL CHEMICAL BIOLOGY, 2021, 28 (02): : 202 - +
  • [43] Deciphering Staphylococcus aureus-host dynamics using dual activity-based protein profiling of ATP-interacting proteins
    Dela Ahator, Stephen
    Hegstad, Kristin
    Lentz, Christian S.
    Johannessen, Mona
    MSYSTEMS, 2024, 9 (05)
  • [44] Activity-based protein profiling in drug/pesticide discovery: Recent advances in target identification of antibacterial compounds
    Chen, Kunlun
    Zhang, Ling
    Ding, Yue
    Sun, Zhaoju
    Meng, Jiao
    Luo, Rongshuang
    Zhou, Xiang
    Liu, Liwei
    Yang, Song
    BIOORGANIC CHEMISTRY, 2024, 151
  • [45] Investigating the mechanism of cancer chemoprevention by aspirin using hyperpolarized MR and activity-based protein profiling
    Ornelas, Argentina
    Millward, Niki Zacharias
    Davis, Jennifer
    Menter, David
    Hawke, David
    Bhattacharya, Pratip
    Sanchez, Eduardo Vilar
    Millward, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [46] Structure Dependent Determination of Organophosphate Targets in Mammalian Tissues Using Activity-Based Protein Profiling
    Lin, Vivian S.
    Volk, Regan F.
    DeLeon, Adrian J.
    Anderson, Lindsey N.
    Purvine, Samuel O.
    Shukla, Anil K.
    Bernstein, Hans C.
    Smith, Jordan N.
    Wright, Aaron T.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (02) : 414 - 425
  • [47] Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation
    Mario Navarrete
    Brice Korkmaz
    Carla Guarino
    Adam Lesner
    Ying Lao
    Julie Ho
    Peter Nickerson
    John A. Wilkins
    Clinical Proteomics, 2020, 17
  • [48] Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation
    Navarrete, Mario
    Korkmaz, Brice
    Guarino, Carla
    Lesner, Adam
    Lao, Ying
    Ho, Julie
    Nickerson, Peter
    Wilkins, John A.
    CLINICAL PROTEOMICS, 2020, 17 (01)
  • [49] Activity-based Protein Profiling Identifies a Host Enzyme, Carboxylesterase 1, Which Is Differentially Active during Hepatitis C Virus Replication
    Blais, David R.
    Lyn, Rodney K.
    Joyce, Michael A.
    Rouleau, Yanouchka
    Steenbergen, Rineke
    Barsby, Nicola
    Zhu, Lin-Fu
    Pegoraro, Adrian F.
    Stolow, Albert
    Tyrrell, David L.
    Pezacki, John Paul
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (33) : 25602 - 25612
  • [50] In-gel activity-based protein profiling of a clickable covalent ERK1/2 inhibitor
    Lebraud, Honorine
    Wright, David J.
    East, Charlotte E.
    Holding, Finn P.
    O'Reilly, Marc
    Heightman, Tom D.
    MOLECULAR BIOSYSTEMS, 2016, 12 (09) : 2867 - 2874